NCT04669210 2025-07-04PTCyRuxoSt. Petersburg State Pavlov Medical UniversityPhase 2 Completed128 enrolled
NCT05663827 2024-03-05Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host DiseaseChang Gung Memorial HospitalPhase 3 Completed6 enrolled
NCT01914484 2020-11-02Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-LeukemiaUniversity Health Network, TorontoPhase 1/2 Completed4 enrolled
NCT02779283 2020-05-26Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaOHSU Knight Cancer InstitutePhase 1 Completed7 enrolled
NCT01164163 2014-10-23INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseChildren's Oncology GroupPhase 1 Completed49 enrolled